TrialEuropean urology oncology2026

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.

Krishnan R Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.